Results 31 to 40 of about 3,323,629 (269)

Androgen Deprivation Therapy and Cardiovascular Risk [PDF]

open access: yesJournal of Clinical Oncology, 2011
Purpose The potential association between androgen deprivation therapy (ADT) and cardiovascular mortality (CVM) remains controversial. This study assessed mortality outcomes in a large national registry to further elucidate the association between treatment selection and cause of mortality.
Sanoj, Punnen   +3 more
openaire   +2 more sources

Metabolic Complications and Increased Cardiovascular Risks as a Result of Androgen Deprivation Therapy in Men with Prostate Cancer

open access: yesProstate Cancer, 2011
Prostate cancer is one of the most common malignancies in men. Charles Huggins and Clarence V. Hodges reported the androgen dependence of prostate cancer in 1941.
Bhavin R. Shastri, Subhashini Yaturu
doaj   +1 more source

Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer

open access: yesEuropean Urology Open Science, 2022
The treatment landscape for metastatic hormone-sensitive prostate cancer (mHSPC) has dramatically evolved. Monotherapy androgen deprivation therapy (ADT) with testosterone suppression alone is no longer the standard of care as multiple global phase 3 ...
Seyed Behzad Jazayeri   +3 more
doaj   +1 more source

Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone [PDF]

open access: yes, 2020
To analyze possible effect of androgen deprivation therapy in preventing SARS-Cov-2 infection and respiratory ...
Mastroianni C. M.   +15 more
core   +1 more source

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.

open access: yesPLoS ONE, 2021
BackgroundMen have a higher risk of death from COVID-19 than women and androgens facilitate entrance of the SARS-CoV-2 virus into respiratory epithelial cells.
Rolf Gedeborg   +4 more
doaj   +1 more source

Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer

open access: yes, 2022
The recommended treatment for high-risk localized or locally advanced prostate cancer is radical prostatectomy plus extended pelvic lymph node dissection or radiation therapy plus long-term androgen deprivation therapy. However, some patients are treated
Hiroaki Iwamoto   +3 more
core   +1 more source

MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner

open access: yesNeoplasia: An International Journal for Oncology Research, 2016
PURPOSE: Increased murine double minute 2 (MDM2) expression, independent of p53 status, is associated with increased cancer-specific mortality for men with prostate cancer treated with radiotherapy.
Felix Y. Feng   +9 more
doaj   +1 more source

Androgen Deprivation Therapy and Alzheimer's Disease [PDF]

open access: yesJournal of Clinical Oncology, 2016
unmeasured or hidden confounders were present to put the hormonal treatment population at a disadvantage. For instance, hormonal treatment could have been used less critically in patients with mild symptoms of dementia or in those of lower socioeconomic status.
Michael, Froehner, Manfred P, Wirth
openaire   +2 more sources

Supplementary Data from Modeling Androgen Deprivation Therapy–Induced Prostate Cancer Dormancy and Its Clinical Implications

open access: yes, 2022
Supplementary Data from Modeling Androgen Deprivation Therapy–Induced Prostate Cancer Dormancy and Its Clinical ...
Dong Lin (280920)   +20 more
core   +1 more source

A qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapy [PDF]

open access: yes, 2012
Background - The severe iatrogenic hypogonadal state induced by medical castration used for treatment of prostate cancer is associated with adverse effects including fatigue, increased fracture risk, and a decrease in skeletal muscle function, which ...
Saxton John M   +31 more
core   +2 more sources

Home - About - Disclaimer - Privacy